Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

被引：0
|
作者：
Bo Guo
Hong-Li Zhu
Hui Fan
Su-Xia Li
Xue-Chun Lu
Jie Lin
Hai-Hong Ran
Bing Zhai
Yang Yang
机构：
[1] General Hospital of People’s Liberation Army,
来源：
Advances in Therapy | 2012年 / 29卷
关键词：
advanced age; chronic lymphocytic leukemia/small lymphocytic lymphoma; fludarabine; individualized regimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 186
页数：8
相关论文
共 50 条
  • [1] Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Guo, Bo
    Zhu, Hong-Li
    Fan, Hui
    Li, Su-Xia
    Lu, Xue-Chun
    Lin, Jie
    Ran, Hai-Hong
    Zhai, Bing
    Yang, Yang
    ADVANCES IN THERAPY, 2012, 29 (02) : 178 - 186
  • [2] A Phase II Trial of Ofatumumab for Older Patients and Patients Who Refuse Fludarabine-Based Regimens with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Flinn, Ian W.
    Harwin, William N.
    Macias-Perez, Ines M.
    Tucker, Patrick S.
    Waterhouse, David M.
    Papish, Steven W.
    Jones, Jeffrey A.
    Hainsworth, John D.
    Byrd, John C.
    BLOOD, 2011, 118 (21) : 1673 - 1673
  • [3] Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia
    Shvidel, L
    Shtalrid, M
    Bairey, O
    Rahimi-Levene, N
    Lugassy, G
    Shpilberg, O
    Polliack, A
    Berrebi, A
    LEUKEMIA & LYMPHOMA, 2003, 44 (11) : 1947 - 1950
  • [4] Phase II Trial of Ofatumumab (OFA) for Older Patients and Patients Who Refuse Fludarabine-Based Regimens with Previously Untreated Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    Flinn, Ian W.
    Harwin, William N.
    Ward, Patrick
    Doss, Habib H.
    Papish, Steven W.
    Hainsworth, John D.
    Berdeja, Jesus G.
    Byrd, John C.
    BLOOD, 2012, 120 (21)
  • [5] Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia
    O'Brien, SM
    Kantarjian, AM
    Cortes, J
    Beran, M
    Koller, CA
    Giles, FJ
    Lerner, S
    Keating, M
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1414 - 1420
  • [6] Nursing considerations for use in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma
    Nierman, Pia
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (06) : 687 - 696
  • [7] Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Awan, Farrukh T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (01) : 13 - 14
  • [8] Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
    Jelloul, Fatima Zahra
    Chen, Qiang Hua
    Yang, Tianyu
    Brody, Judith
    Zhang, Xinmin
    Fayyaz, Silvat Sheikh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A116 - A116
  • [9] Cytogenetic Aberrations in Young Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Liao, Guanghong
    Sajjan, Sujata
    Yang, Tianyu
    Sheikh-Fayyaz, Silvat
    Haghi, Nina
    Zhang, Xinmin
    Wang, Jing
    Chen, Brian
    Brody, Judith
    Reddy, Kalpana
    Hsu, Peihong
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S88 - S88
  • [10] Fludarabine and mitoxantrone for patients with chronic lymphocytic leukemia
    Tsimberidou, AM
    Keating, MJ
    Giles, FJ
    Wierda, WG
    Ferrajoli, A
    Lerner, S
    Beran, M
    Andreeff, M
    Kantarjian, HM
    O'Brien, S
    CANCER, 2004, 100 (12) : 2583 - 2591
12345